Prof. Kin-Ping Wong, Ph.D, is the Dean of the College of Science and Mathematics at California State University, Fresno. He is also an Adjunct Professor in the Departments of Medicine and Biochemistry and Biophysics at the University of California, San Francisco. Dr. Wong is also currently the Founder and Chairman of the Board of Angiogen, Inc., based in San Diego, California. His current research focuses on the discovery and development of novel anti-angiogenic therapeutics targeting the vascular network for the treatment of neovascular-based diseases such as cancer and arthritis.

In addition to having been the Founder, Chairman, and CEO of RiboGene Inc., in Dublin, California, Dr. Wong has held positions as Program Director in Biophysics at the National Science Foundation in Washington, D.C., as well as Managing Director and CEO of the Hong Kong Institute of Biotechnology in Hong Kong. Dr. Wong has served on a number of boards for research institutes and has consulted for a number of biotechnology companies and venture capital firms. He has published over 60 peer-reviewed articles in the scientific literature, and is a named inventor on a number of pending U.S. patents.